These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32545906)

  • 1. Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework.
    Capina R; Li K; Kearney L; Vandamme AM; Harrigan PR; Van Laethem K
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
    Lee ER; Gao F; Sandstrom P; Ji H
    Viruses; 2020 May; 12(5):. PubMed ID: 32429382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
    Ávila-Ríos S; Parkin N; Swanstrom R; Paredes R; Shafer R; Ji H; Kantor R
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32516949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays.
    Becker MG; Liang D; Cooper B; Le Y; Taylor T; Lee ER; Wu S; Sandstrom P; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.
    Ji H; Parkin N; Gao F; Denny T; Jennings C; Sandstrom P; Kantor R
    Viruses; 2020 May; 12(5):. PubMed ID: 32443529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing.
    Jennings C; Parkin NT; Zaccaro DJ; Capina R; Sandstrom P; Ji H; Brambilla DJ; Bremer JW
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
    Ji H; Enns E; Brumme CJ; Parkin N; Howison M; Lee ER; Capina R; Marinier E; Avila-Rios S; Sandstrom P; Van Domselaar G; Harrigan R; Paredes R; Kantor R; Noguera-Julian M
    J Int AIDS Soc; 2018 Oct; 21(10):e25193. PubMed ID: 30350345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
    Lee ER; Parkin N; Jennings C; Brumme CJ; Enns E; Casadellà M; Howison M; Coetzer M; Avila-Rios S; Capina R; Marinier E; Van Domselaar G; Noguera-Julian M; Kirkby D; Knaggs J; Harrigan R; Quiñones-Mateu M; Paredes R; Kantor R; Sandstrom P; Ji H
    Sci Rep; 2020 Jan; 10(1):1634. PubMed ID: 32005884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.
    Manyana S; Gounder L; Pillay M; Manasa J; Naidoo K; Chimukangara B
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34208165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing.
    Noguera-Julian M; Lee ER; Shafer RW; Kantor R; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32575676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of Next-generation Sequencing Techniques in the Dynamics of HIV-1 Quasispecies].
    Zhang J; Xing H
    Bing Du Xue Bao; 2015 Sep; 31(5):573-8. PubMed ID: 26738298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.
    Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H
    Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.
    Jenkins F; Le T; Farhat R; Pinto A; Anzari A; Bonsall D; Golubchik T; Bowden R; Lee FJ; van Hal SJ
    J Med Virol; 2023 Dec; 95(12):e29273. PubMed ID: 38050831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Sequencing for HIV-1 Drug Resistance Testing-A Special Issue Walkthrough.
    Kantor R
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technologies for HIV-1 drug resistance testing: inventory and needs.
    Metzner KJ
    Curr Opin HIV AIDS; 2022 Jul; 17(4):222-228. PubMed ID: 35762377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
    Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
    J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.